Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
J Am Acad Dermatol ; 83(1): 184-188, 2020 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-31821858

RESUMO

Extemporaneous compounding is a means to tailor a medication to an individual patient's needs and may be required when no commercial product exists to meet that need. Compounded products range from buffered lidocaine to topical creams and ointments. Recent heightened regulations have made compounding more challenging for dermatologists and prompted this review of regulations, liability, and safety related to compounding. With this information, providers may minimize liability and maximize safety while caring for their patients.


Assuntos
Composição de Medicamentos , Composição de Medicamentos/economia , Composição de Medicamentos/normas , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Humanos , Tecnologia Farmacêutica/legislação & jurisprudência , Estados Unidos , United States Food and Drug Administration
3.
Dermatol Surg ; 44(9): 1216-1219, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-29781906

RESUMO

BACKGROUND: As the demand for cosmetic treatments increases, it is important for dermatology residents to be educated about and achieve proficiency in dermatologic cosmetic procedures. OBJECTIVE: To assess dermatology residents' educational exposure to cosmetic dermatology. MATERIALS AND METHODS: An anonymous 18-question survey was sent electronically to 1,266 dermatology residents requesting information about cosmetic dermatology training during residency. RESULTS: Two hundred sixty-eight residents responded to the survey (21% response rate). Most residents receive didactic instruction (94%) and hands-on training (91%) on cosmetic dermatology topics during residency. Survey participants in residency programs perceived as supportive of cosmetic dermatology training are more frequently provided lectures (70% vs 31%, p < .001) and procedural training (100% vs 69%, p < .001) in cosmetic dermatology as compared to residents in unsupportive programs. Eighty-nine percent of respondents reported hands-on training as the most effective method for developing proficiency in cosmetic procedures. CONCLUSION: Providing safe and competent patient care should serve as the impetus for expanding cosmetic dermatology education and training for residents.


Assuntos
Dermatologia/educação , Internato e Residência , Atitude do Pessoal de Saúde , Competência Clínica , Currículo , Humanos , Autoavaliação (Psicologia) , Inquéritos e Questionários
5.
Arch Dermatol ; 141(7): 869-72, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16027303

RESUMO

BACKGROUND: The development of granulomatous lesions within tattoos is a well-recognized occurrence in individuals with sarcoidosis. The characteristic histopathological finding of sarcoidosis is the presence of noncaseating granulomas; however, similar histopathogical findings may be seen in foreign body granulomas. Several reports have challenged the assertion that the presence of foreign material within sarcoidal granulomas is incompatible with a diagnosis of sarcoidosis. OBSERVATIONS: We describe a patient who had multiple linearly arranged papules along her eyebrows and the vermillion border of her upper lip. She had had cosmetic tattooing performed on these areas 3 year prior to presentation. Histopathologic examination revealed sarcoidal granulomas, polarizable foreign material, and pigment granules. Hilar adenopathy was noted on a chest radiograph. After 4 months of treatment with a midpotency topical steroid and doxycycline, she experienced complete clearance of her cutaneous lesions and normalization of chest x-ray film findings. CONCLUSIONS: This case demonstrates a unique adverse result after cosmetic tattooing and highlights the concept that granulomatous histopathologic findings containing foreign material should not be an exclusionary criterion for the diagnosis of sarcoidosis. In this setting, further investigation for the presence of systemic disease is indicated.


Assuntos
Sarcoidose/tratamento farmacológico , Sarcoidose/etiologia , Dermatopatias/tratamento farmacológico , Dermatopatias/etiologia , Tatuagem/efeitos adversos , Administração Tópica , Adulto , Biópsia por Agulha , Doxiciclina/uso terapêutico , Quimioterapia Combinada , Feminino , Seguimentos , Humanos , Imuno-Histoquímica , Medição de Risco , Sarcoidose/patologia , Dermatopatias/patologia , Esteroides/uso terapêutico , Resultado do Tratamento
7.
Pediatr Dermatol ; 22(3): 210-2, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-15916566

RESUMO

We report a rare childhood occurrence of melanoma in situ presenting as diffuse nail pigmentation resulting from expanding longitudinal melanonychia, and discuss factors that should come into play when considering a possible nail matrix biopsy.


Assuntos
Melanoma/diagnóstico , Doenças da Unha/diagnóstico , Neoplasias Cutâneas/diagnóstico , Carcinoma in Situ/diagnóstico , Carcinoma in Situ/patologia , Criança , Diagnóstico Diferencial , Feminino , Dedos , Humanos , Melanoma/patologia , Doenças da Unha/patologia , Neoplasias Cutâneas/patologia
8.
J Am Acad Dermatol ; 50(2): 315-8, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-14726895

RESUMO

Neutrophilic eccrine hidradenitis is a nonspecific clinical reaction pattern classified as a neutrophilic dermatosis that typically occurs in the setting of chemotherapy for hematologic malignant disease. Neutrophilic eccrine hidradenitis more rarely has been reported in association with infectious agents, including Serratia, Enterobacter, Staphylococcus, and HIV. We describe the first case of infectious eccrine hidradenitis occurring in a patient with cutaneous Nocardia infection.


Assuntos
Hidradenite/etiologia , Hidradenite/microbiologia , Nocardiose/complicações , Nocardia/patogenicidade , Idoso , Idoso de 80 Anos ou mais , Anti-Infecciosos/uso terapêutico , Feminino , Hidradenite/patologia , Humanos , Nocardia/isolamento & purificação , Nocardiose/tratamento farmacológico , Combinação Trimetoprima e Sulfametoxazol/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA